Total Neoadjuvant Treatment for Esophageal Adenocarcinoma With Oligometastases: <scp>TNT</scp> ‐ <scp>OES</scp> ‐1 Trial
Charlène J. van der Zijden(Erasmus MC Cancer Institute), S M Lagarde(Erasmus MC Cancer Institute), Leni van Doorn(Erasmus MC), Ben M. Eyck(Erasmus MC Cancer Institute), M Y V Homs(Erasmus MC), Joost J. Nuyttens(Erasmus MC Cancer Institute), Ate van der Gaast(Erasmus MC), Tamara J. Huizer(Erasmus MC Cancer Institute), Bianca Mostert(Erasmus MC), J. Jan B. van Lanschot(Erasmus MC Cancer Institute), Lindsey Oudijk(Erasmus MC), Bas P. L. Wijnhoven(Erasmus MC Cancer Institute), Manon C.W. Spaander(Erasmus University Rotterdam)
Cited by 0
Related Papers
Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC Trial
|Journal of Clinical Oncology|2020|1.1k
Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial
|Journal of Clinical Oncology|2021|788
Paediatric Gastrointestinal Endoscopy
|Journal of Pediatric Gastroenterology and Nutrition|2016|274